Agile Therapeutics, Inc.
AGRX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,465 | -$25,412 | -$74,894 | -$51,853 |
| Dep. & Amort. | $386 | $1,534 | $2,223 | $276 |
| Deferred Tax | -$5,959 | $0 | $5,323 | $0 |
| Stock-Based Comp. | $1,981 | $2,493 | $3,338 | $2,818 |
| Change in WC | $7,417 | -$2,133 | -$2,853 | $107 |
| Other Non-Cash | $1,063 | -$12,429 | $1,661 | $1,341 |
| Operating Cash Flow | -$9,577 | -$35,947 | -$65,202 | -$47,311 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$133 | -$269 | -$353 |
| Net Acquisitions | $0 | $0 | $0 | $353 |
| Inv. Purchases | $0 | $0 | $0 | -$54,837 |
| Inv. Sales/Matur. | $0 | $0 | $39,729 | $14,500 |
| Other Inv. Act. | $0 | -$133 | $39,729 | -$353 |
| Investing Cash Flow | $0 | -$133 | $39,460 | -$40,690 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,347 | -$17,375 | $0 | $20,000 |
| Stock Issued | $8,235 | $35,430 | $30,347 | $48,434 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $15,295 | $4,128 | $75 | -$449 |
| Financing Cash Flow | $6,888 | $22,183 | $30,422 | $67,985 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,689 | -$13,897 | $4,680 | -$20,016 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,246 | $19,143 | $14,463 | $34,479 |
| End Cash | $2,557 | $5,246 | $19,143 | $14,463 |
| Free Cash Flow | -$9,577 | -$36,080 | -$65,471 | -$47,664 |